278 results on '"Church, David N"'
Search Results
2. Non-Canonical Activin A Signaling Stimulates Context-Dependent and Cellular-Specific Outcomes in CRC to Promote Tumor Cell Migration and Immune Tolerance.
3. Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
4. Standardizing data collection in adjuvant colon cancer trials: A consensus project from the IDEA and ACCENT international consortia and national experts
5. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II–III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis
6. Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
7. IL7 genetic variation and toxicity to immune checkpoint blockade in patients with melanoma
8. Patterns of cytotoxic T-cell densities in immunogenic endometrial cancers reveal a potential mechanism for differences in immunotherapy efficacy
9. A clinical decision support system optimising adjuvant chemotherapy for colorectal cancers by integrating deep learning and pathological staging markers: a development and validation study
10. Tertiary lymphoid structures critical for prognosis in endometrial cancer patients
11. Promises and challenges of adoptive T-cell therapies for solid tumours
12. The Glasgow Microenvironment Score associates with prognosis and adjuvant chemotherapy response in colorectal cancer
13. Prediction of relapse-free survival according to adjuvant chemotherapy and regulator of chromosome condensation 2 (RCC2) expression in colorectal cancer
14. Rationale and design of the POLEM trial: avelumab plus fluoropyrimidine-based chemotherapy as adjuvant treatment for stage III mismatch repair deficient or POLE exonuclease domain mutant colon cancer: a phase III randomised study
15. The English National Lynch Syndrome transformation project: an NHS Genomic Medicine Service Alliance (GMSA) programme
16. Functional analysis reveals driver cooperativity and novel mechanisms in endometrial carcinogenesis
17. Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
18. More than just a hangover – alcohol and carcinogenesis in Lynch syndrome
19. Hypermutated Colorectal Cancer and Neoantigen Load
20. Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
21. Changing Practice Evaluation—Stage 1 Seminoma: Outcomes With Adjuvant Treatment Versus Surveillance: Risk Factors for Recurrence and Optimizing Follow-up Protocols—Experience From a Supraregional Center
22. Tumour-infiltrating CD8+ lymphocytes and colorectal cancer recurrence by tumour and nodal stage
23. Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets
24. Value of Supraregional Multidisciplinary Review for the Contemporary Management of Testicular Tumors
25. Genetics and genetic instability in cancer
26. Somatic POLE proofreading domain mutation, immune response, and prognosis in colorectal cancer: a retrospective, pooled biomarker study
27. Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
28. Data from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
29. Supplementary Table 7 from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
30. Supplementary Tables 1-6, 8 from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
31. Supplementary Figures from A Transcriptionally Distinct CXCL13+CD103+CD8+ T-cell Population Is Associated with B-cell Recruitment and Neoantigen Load in Human Cancer
32. Supplementary Data from Prognostic Integrated Image-Based Immune and Molecular Profiling in Early-Stage Endometrial Cancer
33. Supplementary figure 6 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
34. Supplementary Table S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
35. Table S3 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
36. Supplementary figure 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
37. Figure S1 from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
38. Supplementary figure 4 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
39. Supplementary table 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
40. Supplementary Figure S2 from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
41. Supplementary figure 5 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
42. Supplementary Methods from Adjuvant Treatment for POLE Proofreading Domain–Mutant Cancers: Sensitivity to Radiotherapy, Chemotherapy, and Nucleoside Analogues
43. Supplementary Methods from Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
44. Supplementary figure 2 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
45. Supplementary figure 3 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
46. Supplementary table 1 from POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer
47. Prognostic significance of L1CAM expression and its association with mutant p53 expression in high-risk endometrial cancer
48. Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative
49. Abstract B013: Activin’s influence on the tumor microenvironment in colon cancer
50. Colorectal Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.